What Quality by Design Means for Modern Pharma DevelopmentUntitledBuilding Quality in, Not Testing It Out
Quality by Design (QbD) is a systematic, science-based approach to pharmaceutical and biopharmaceutical development that builds quality into a product from the design stage rather than testing it in at the end. This one-day Quality by Design training in Germany gives scientists, engineers and quality professionals the tools to apply QbD on live development projects. Grounded in the ICH Q8(R2) Pharmaceutical Development guideline and the wider ICH Q9, Q10 and Q11 framework, the course shows you how to define a Quality Target Product Profile, identify Critical Quality Attributes, run risk assessment and Design of Experiments, and build a robust Control Strategy that regulators such as the EMA and FDA increasingly expect. Germany is the second-largest producer of biopharmaceuticals in the EU, and employers from Bayer and Boehringer Ingelheim to BioNTech and a fast-growing CDMO base value professionals who can design quality in from the outset. Start building that capability with Invensis Learning.










